3,138
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Antitumor activity of intratracheal inhalation of temozolomide (TMZ) loaded into gold nanoparticles and/or liposomes against urethane-induced lung cancer in BALB/c mice

, , &
Pages 599-607 | Received 04 Aug 2016, Accepted 10 Oct 2016, Published online: 26 Feb 2017

References

  • Bancroft JD, Gamble M. (2008). Theory and practice of histological techniques. Philadelphia (PA): Elsevier Health Sciences
  • Bernert H, Sekikawa K, Radcliffe RA, et al. (2003). Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog 38:117–23
  • Bhattacharya R, Patra CR, Verma R, et al. (2007). Gold nanoparticles inhibit the proliferation of multiple myeloma cells. Adv Mat 19:711–16
  • Bivas-Benita M, Zwier R, Junginger HE, et al. (2005). Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61:214–18
  • Broughton-Head VJ, Smith JR, Shur J, et al. (2007). Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm Pharmacol Ther 20:708–17
  • Cekanova M, Lee SH, Donnell RL, et al. (2009). Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila) 2:450–8
  • Chen G, Roy I, Yang C, et al. (2016). Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chemical Rev 5:2826–85
  • Chithrani BD, Ghazani AA, Chan WC. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–8
  • Correard F, Maximova K, Estève MA, et al. (2014). Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications. Int J Nanomed 9:5415
  • Drury RaB, Wallington E. (1967). Carleton's histological technique. 4th ed. London: Oxford University Press
  • Fanciullino R, Ciccolini J, Milano G. (2013). Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs. Crit Rev Oncol Hematol 88:504–13
  • Ferreira GK, Cardoso E, Vuolo FS, et al. (2015). Gold nanoparticles alter parameters of oxidative stress and energy metabolism in organs of adult rats. Biochem Cell Biol 93:548–57
  • Gao J, Wang Z, Liu H, et al. (2015). Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation. Drug Discov Therap 9:205–12
  • Guo S, Huang L. (2014). Nanoparticles containing insoluble drug for cancer therapy. Biotechnol Adv 32:778–88
  • Hamzawy MA, Abo-Youssef AM, Salem HF, Ali SM. (2015). An additional risk of lung cancer from recurrent exposure to ethyl carbamate (EC) in BALB/C mice. J Cancer Sci Therap 2015:7–11
  • Hussain S. (2016). Nanomedicine for treatment of lung cancer. In: Ahmad A, Gadgeel SM, eds. Lung cancer and personalized medicine: novel therapies and clinical management. London: Springer, 137–47
  • Iodice C, Cervadoro A, Palange A, et al. (2016). Enhancing photothermal cancer therapy by clustering gold nanoparticles into spherical polymeric nanoconstructs. Optics Lasers Eng 76:74–81
  • Klimiankou M, Lindau R, Möslang A. (2005). Energy-filtered TEM imaging and EELS study of ODS particles and argon-filled cavities in ferritic-martensitic steels. Micron 36:1–8
  • Kojima C, Hirano Y, Yuba E, et al. (2008). Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids Surf B Biointerfaces 66:246–52
  • Kowaltowski AJ, De Souza-Pinto NC, Castilho RF, et al. (2009). Mitochondria and reactive oxygen species. Free Radic Biol Med 47:333–43
  • Lee DS, Park KR, Kim SJ, et al. (2015). Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes. Tum Bio 37:619–25
  • Lévy R, Thanh NT, Doty RC, et al. (2004). Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J Am Chem Socie 126:10076–84
  • Li XT, He ML, Zhou ZY, et al. (2015). The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation. Int J Pharm 487:223–33
  • Liu M, Zhao Y, Zhang X. (2015a). Knockdown of glutamate cysteine ligase catalytic subunit by siRNA causes the gold nanoparticles-induced cytotoxicity in lung cancer cells. PLoS One 10:e0118870
  • Liu X, Yang Z, Chen Z, et al. (2015b). Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells. Oncol Rep 33:157–62
  • Liu J, Yu M, Zhou C, et al. (2013). Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. J Am Chem Soc 135:4978–81
  • Maccallum C, Gillenwater HH. (2006). Second-line treatment of small-cell lung cancer. Curr Oncol Rep 8:258–64
  • Mallick S, Roy S, Joshi NP, Julka PK. (2015). Primary spinal melanoma treated with adjuvant radiotherapy and concurrent temozolomide: a case report and review of literature. J Cancer Res Ther 11:1027
  • Manuja A, Kumar B, Singh RK. (2012). Nanotechnology developments: opportunities for animal health and production. Nanotechnol Dev 2:e4
  • Mohammed MI, Makky AM, Teaima MH, et al. (2015). Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study. Drug Deliv 23:1558–64
  • Murray N, Turrisi AT III. (2006). A review of first-line treatment for small-cell lung cancer. J Thorac Oncol 1:270–8
  • Nakahara SB, Sanches DS, Caniceiro BD, et al. (2013). Effects of selenium on Pteridium aquilinum and urethane-induced lung carcinogenesis. Immunopharmacol Immunotoxicol 35:605–14
  • Narayan C, Kumar A. (2012). Constitutive over expression of IL-1β, IL-6, NF-κB, and Stat3 is a potential cause of lung tumorgenesis in urethane (ethyl carbamate) induced Balb/c mice. J Carcinog 11:9
  • Nie S. (2010). Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) 5:523–28
  • Orza A, Soritau O, Tomuleasa C, et al. (2013). Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles. Int J Nanomedicine 8:689–702
  • Pandey M, Gupta KP. (2012). Involvement of STAT3, NF-κB and associated downstream molecules before and after the onset of urethane induced lung tumors in mouse. Environ Toxicol Pharmacol 34:502–11
  • Park SH, Oh SG, Mun JY, Han SS. (2006). Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities. Colloids Surf B Biointerfaces 48:112–18
  • Pommier Y, Leo E, Zhang H, et al. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–33
  • Prabhakar U, Maeda H, Jain RK, et al. (2013). Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73:2412–17
  • Qian Z, Wang X, Song Z, et al. (2015). A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors. Biomed Res Int 2015:809714
  • Rao JP, Geckeler KE. (2011). Polymer nanoparticles: preparation techniques and size-control parameters. Progress Polymer Sci 36:887–913
  • Riaz M. (1996). Liposomes preparation methods. Pak J Pharm Sci 9:65–77
  • Salem HF, Ahmed SM, Hassaballah AE, et al. (2015). Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study. Drug Des Devel Ther 9:3705–27
  • Schiller JH. (2001). Current standards of care in small-cell and non-small-cell lung cancer. Oncology 61:3–13
  • Stathopoulos GT, Sherrill TP, Cheng DS, et al. (2007). Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci USA 104:18514–19
  • Stokes ME, Davis CS, Koch GG. (2012). Categorical data analysis using SAS. Cary (NC): SAS Institute
  • Surh YJ, Kim SG, Park KK, et al. (1998). Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis and tumorigenesis induced by vinyl carbamate or vinyl carbamate epoxide. Carcinogenesis 19:1263–7
  • Takahashi H, Kurishima K, Ishikawa H, et al. (2010). Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis. Anticancer Res 30:3833–7
  • Tang H, Liao Y, Xu L. (2013). Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice. Int J Cancer 133:2473–82
  • Torre LA, Siegel RL, Jemal A. (2016). Lung cancer statistics. In: Ahmad A, Gadgeel SM, eds. Lung cancer and personalized medicine: novel therapies and clinical management. London: Springer, 1–19
  • Treda CJ, Fukuhara T, Suzuki T, et al. (2013). Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis. Carcinogenesis 35:896–904
  • Vandooren J, Opdenakker G, Loadman PM, et al. (2016). Proteases in cancer drug delivery. Adv Drug Deliv Rev 97:144–55
  • Waller RA, Duncan DB. (1969). A Bayes rule for the symmetric multiple comparisons problem. J Am Stat Assoc 64:1484–503
  • Wauthoz N, Deleuze P, Hecq J, et al. (2010). In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. Eur J Pharm Sci 39:402–11
  • Wieskopf B, Demangeat C, Purohit A, et al. (1995). Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest 108:163–9
  • Willder JM, Thomson AM, Grigor KM, et al. (2012). A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis. Can Urol Assoc J 6:364–6
  • Wu L, Zhang J, Watanabe W. (2011). Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 63:456–69
  • Xie Y, Aillon KL, Cai S, et al. (2010). Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. Int J Pharm 392:156–63
  • Xu P, Le Pechoux C. (2015). Chemoradiotherapy for stage III non-small cell lung cancer: have we reached the limit? Chin Clin Oncol 4:45
  • Yamagata T, Yamagata Y, Nakanishi M, et al. (2004). A case of primary lung cancer producing alpha-fetoprotein. Can Respir J11:504–6
  • Yonezawa T, Kunitake T. (1999). Practical preparation of anionic mercapto ligand-stabilized gold nanoparticles and their immobilization. Colloids Surf A Physicochem Eng Asp 149:193–9
  • Zhang N, Chen H, Liu AY, et al. (2016). Gold conjugate-based liposomes with hybrid Cluster Bomb structure for liver cancer therapy. Biomat 74:280–91
  • Zhou X, Chen R, Xie W, et al. (2014). Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas. J Nucl Med 55:1766–71